Results 81 to 90 of about 27,891 (163)

Optical coherence tomography findings in Duchenne muscular dystrophy. [PDF]

BMC Ophthalmol
Yöyler G, Adıyeke SK.
europepmc   +1 more source

Exosome-Mediated Benefits of Cell Therapy in Mouse and Human Models of Duchenne Muscular Dystrophy. [PDF]

Stem Cell Reports
Aminzadeh MA, Rogers RG, Fournier M, Tobin RE, Guan X, Childers MK, Andres AM, Taylor DJ, Ibrahim A, Ding X, Torrente A, Goldhaber JM, Lewis M, Gottlieb RA, Victor RA, Marbán E.   +15 more
europepmc   +1 more source

YAP Acts as a Negative Regulator of Mini Utrophin-Based Gene Therapy for Duchenne Muscular Dystrophy in Mdx Mice. [PDF]

Int J Mol Sci
Li Z, Song Y.
europepmc   +1 more source

Creatine/Creatinine Ratio and Myostatin as Biomarkers to Monitor Muscle Function in Duchenne Muscular Dystrophy Patients. [PDF]

J Cachexia Sarcopenia Muscle
Degan C, Tsonaka R, de Vries SI, Ikelaar NA, van der Holst M, Kan HE, Niks EH, Spitali P.   +7 more
europepmc   +1 more source

Systematic Literature Reviews of Health-State Utility Values, Costs, and Healthcare Resource Use in Duchenne Muscular Dystrophy. [PDF]

J Health Econ Outcomes Res
Yip CY, Kemadjou EN, Stewart D, Shapiro H, Macmillan T.   +4 more
europepmc   +1 more source

FDA-approved antisense oligonucleotide therapies for duchenne muscular dystrophy: current status and future outlook. [PDF]

RNA Biol
Moriyama H, Moriyama S, Yokota T.
europepmc   +1 more source

Neonatal screening for Duchenne muscular dystrophy in eastern China: a closed prospective study. [PDF]

Transl Pediatr
Qian G, Yang R, Huang X, Wu D, Fang K, Zhao Z.   +5 more
europepmc   +1 more source

State-of-the-Art Research and New Pharmacological Perspectives on Renal Involvement in Duchenne Muscular Dystrophy: A Narrative Review. [PDF]

Biomedicines
Bellis M, Imbrici P, Lenti R, Liantonio A, De Luca A.   +4 more
europepmc   +1 more source

Duchenne Muscular Dystrophy: Contemporary Therapeutic Options and Real-World Challenges in Treatment Selection. [PDF]

Muscles
Pesco MT, Öztürk GZ, Bhadola SC, Chrzanowski SM, Gushchina LV, D'Ambrosio ES.   +5 more
europepmc   +1 more source